生命科学资讯

J&J backs financing round for Stanford CAR-T cell therapy spinout Link Cell

OrsoBio obesity data; Monte Rosa's prostate cancer pill; Development pacts for Adaptive and SandboxAQ

Calming nerves with a hot wearable

Chronic pain biotech Ambros Therapeutics emerges with $125M and Vivek Ramaswamy on board

Aeovian gets $55M for tuberous sclerosis complex, to explore prospects in obesity

RTW startup signs autoimmune antibody pact with China’s GenSci

FDA extends decision on Aldeyra's dry eye disease drug

Lenz discloses case of retinal tear in presbyopia eye drop patient

FDA wants to use more real-world data and calls again for early-phase trials reform

Enhertu combo wins FDA approval for first-line use in metastatic breast cancer

FDA speeds up review of J&J's multiple myeloma combo treatment following positive data

With GLP-1 microdoses, Noom targets lower-BMI group outside FDA obesity drug labels

Gilead posts second Phase 3 win for new HIV-fighting drug regimen

Aviceda's geographic atrophy drug fails mid-stage study. Can it do better in Phase 3?

Palvella unwraps Phase 2 data for rapamycin gel in rare skin disease

Areteia Therapeutics to wind down after terminating Phase 3 asthma studies

Immunome's rare tumor drug passes Phase 3 test, could challenge Merck KGaA

Sanofi returns to Dren Bio for another B cell depletion therapy at $100M upfront

AI biotech Chai Discovery raises $130M Series B at $1.3B valuation

Western genetic medicine makers turn to Chinese investigator-initiated trials